NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 240 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,246,614 | +340.0% | 326,485 | +376.7% | 0.01% | +300.0% |
Q1 2023 | $1,192,463 | +4988.8% | 68,493 | +2600.8% | 0.00% | – |
Q4 2022 | $23,433 | -89.3% | 2,536 | -90.0% | 0.00% | -100.0% |
Q3 2022 | $218,000 | -98.3% | 25,309 | -98.3% | 0.00% | -97.6% |
Q2 2022 | $12,471,000 | +295.5% | 1,530,141 | +489.6% | 0.04% | +310.0% |
Q1 2022 | $3,153,000 | -76.7% | 259,509 | -34.4% | 0.01% | -78.3% |
Q4 2021 | $13,507,000 | +90.6% | 395,881 | +169.4% | 0.05% | +31.4% |
Q1 2021 | $7,086,000 | +464.6% | 146,931 | +242.3% | 0.04% | +400.0% |
Q4 2019 | $1,255,000 | -39.4% | 42,922 | -54.5% | 0.01% | -46.2% |
Q2 2019 | $2,071,000 | +275.9% | 94,386 | +250.6% | 0.01% | +225.0% |
Q1 2019 | $551,000 | +308.1% | 26,918 | +60.5% | 0.00% | +300.0% |
Q2 2016 | $135,000 | +11.6% | 16,772 | -25.1% | 0.00% | 0.0% |
Q2 2015 | $121,000 | +23.5% | 22,390 | +6.6% | 0.00% | 0.0% |
Q1 2015 | $98,000 | – | 21,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |